RG
Redmile Group’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-490,394
| Closed | -$8.38M | – | 53 |
|
2025
Q1 | $8.38M | Sell |
490,394
-81,430
| -14% | -$1.39M | 0.79% | 26 |
|
2024
Q4 | $14.2M | Sell |
571,824
-70,405
| -11% | -$1.74M | 0.99% | 29 |
|
2024
Q3 | $18.3M | Sell |
642,229
-77,948
| -11% | -$2.22M | 1.08% | 32 |
|
2024
Q2 | $19M | Sell |
720,177
-249,444
| -26% | -$6.59M | 1.15% | 32 |
|
2024
Q1 | $31.3M | Sell |
969,621
-7,451
| -0.8% | -$241K | 1.15% | 31 |
|
2023
Q4 | $41.2M | Sell |
977,072
-125,442
| -11% | -$5.28M | 1.47% | 19 |
|
2023
Q3 | $42.3M | Sell |
1,102,514
-818,638
| -43% | -$31.4M | 2.01% | 12 |
|
2023
Q2 | $36.4M | Buy |
1,921,152
+604,121
| +46% | +$11.5M | 1.4% | 23 |
|
2023
Q1 | $20.4M | Buy |
1,317,031
+228,900
| +21% | +$3.55M | 0.89% | 41 |
|
2022
Q4 | $19.3M | Buy |
+1,088,131
| New | +$19.3M | 0.79% | 37 |
|
2020
Q4 | – | Sell |
-120,940
| Closed | -$4.26M | – | 91 |
|
2020
Q3 | $4.26M | Sell |
120,940
-479,060
| -80% | -$16.9M | 0.08% | 73 |
|
2020
Q2 | $14.6M | Buy |
+600,000
| New | +$14.6M | 0.27% | 62 |
|